Refractory gastrointestinal symptoms improved with transition to continuous subcutaneous Foslevodopa/Foscarbidopa infusion in advanced Parkinson's disease
Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100478
DOI: 10.1016/j.prdoa.2026.100478 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Hanouf Aljuaid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa, Ontario, Canada.
- The Ottawa Hospital Research Institute, Ontario, Ottawa, Canada.
Zitieren
APA
Aljuaid, H., Garg, S., & Amorelli, G. (2026). Refractory gastrointestinal symptoms improved with transition to continuous subcutaneous Foslevodopa/Foscarbidopa infusion in advanced Parkinson's disease. Clinical Parkinsonism & Related Disorders, 15, 100478. https://doi.org/10.1016/j.prdoa.2026.100478
Vancouver
Aljuaid H, Garg S, Amorelli G. Refractory gastrointestinal symptoms improved with transition to continuous subcutaneous Foslevodopa/Foscarbidopa infusion in advanced Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2026;15:100478. doi:10.1016/j.prdoa.2026.100478
BibTeX
@article{Aljuaid2026,
author = {Aljuaid, Hanouf and Garg, Surabhi and Amorelli, Gabriel},
title = {Refractory gastrointestinal symptoms improved with transition to continuous subcutaneous Foslevodopa/Foscarbidopa infusion in advanced Parkinson's disease},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2026},
volume = {15},
pages = {100478},
doi = {10.1016/j.prdoa.2026.100478}
}
EUVIMED